Science and Technology · Biotechnology & Cancer Therapy
With reference to NexCAR19, consider the following statements: I. It is an indigenously developed Chimeric Antigen Receptor T-cell (CAR-T) therapy in India. II. It is primarily intended for the treatment of certain blood cancers. III. A key concern associated with NexCAR19 is the comparatively higher occurrence of severe Cytokine Release Syndrome (CRS) than earlier CAR-T therapies. Which of the statements given above is/are correct?
- 1I and II only✓
- 2II and III only
- 3I only
- 4I, II and III
Correct answer
I and II only
Download Single Question PDF
Save this question and verified answer as a clean study sheet with live clickable link.
Share with Friends & Study Groups
Challenge your peer aspirants on WhatsApp or Telegram to solve this question!
Preparing for Science and Technology?
Practice full-length mock tests with real exam timers, instant score analysis, and all-India ranking.
Want more practice questions on Biotechnology & Cancer Therapy?
Solve complete topic-wise tests with detailed solutions on GkGet.
Related Practice Questions
Recommended practice questions in Science and Technology · Biotechnology & Cancer Therapy